1
Department of internal medicine, schoold of medicine, zahedan univ med sci, zahedan, iran
2
Department of Internal Medicine, Zahedan Univ Med Sci
3
Department of Internal Medicine
10.22038/rcm.2026.93558.1576
Abstract
Background Gout is an increasingly recognized public health concern in low- and middle-income regions experiencing rapid socioeconomic change. However, contemporary evidence from southeastern Iran is limited. This study provides the first population-based estimate of gout prevalence in Zahedan and examines its association with demographic, metabolic, and medication-related factors. Methods This cross-sectional analysis included 6,322 adults from the Persian Cohort in Zahedan, with a clinically profiled subsample of 2,166 participants aged 35–75 years. Gout diagnosis was based on standardized clinical criteria. Associations with age, sex, body mass index, comorbidities, and medication use were assessed using univariate and multivariable models. Results The overall prevalence of gout was 5.7% (95% CI: 5.1–6.3%) in the full cohort and 4.7% (95% CI: 3.8–5.6%) in the subsample. Contrary to global literature, gout was not significantly associated with older age, male sex, obesity, hypertension, or diabetes. Instead, loop diuretic use particularly furosemide demonstrated a strong independent association with gout after adjustment for confounders, whereas other medications, alcohol consumption, and cardiometabolic conditions did not show significant relationships. Conclusion Gout affects nearly one in twenty adults in Zahedan, representing a meaningful disease burden. While traditional predictors were not influential, furosemide use emerged as a key modifiable risk factor, emphasizing the need for medication review and gout monitoring among patients receiving loop diuretics. Longitudinal studies incorporating genetic, dietary, and biochemical profiling are warranted to refine prevention and management strategies in this region.
Nosratzehi, S. , Nosratzehi, M. , Dehvari, A. and Mohammadi, M. (2026). Epidemiology of Gout in Southeast Iran: Unexpected Risk Factor Patterns in a Population-Based Study. Reviews in Clinical Medicine, (), -. doi: 10.22038/rcm.2026.93558.1576
MLA
Nosratzehi, S. , , Nosratzehi, M. , , Dehvari, A. , and Mohammadi, M. . "Epidemiology of Gout in Southeast Iran: Unexpected Risk Factor Patterns in a Population-Based Study", Reviews in Clinical Medicine, , , 2026, -. doi: 10.22038/rcm.2026.93558.1576
HARVARD
Nosratzehi, S., Nosratzehi, M., Dehvari, A., Mohammadi, M. (2026). 'Epidemiology of Gout in Southeast Iran: Unexpected Risk Factor Patterns in a Population-Based Study', Reviews in Clinical Medicine, (), pp. -. doi: 10.22038/rcm.2026.93558.1576
CHICAGO
S. Nosratzehi , M. Nosratzehi , A. Dehvari and M. Mohammadi, "Epidemiology of Gout in Southeast Iran: Unexpected Risk Factor Patterns in a Population-Based Study," Reviews in Clinical Medicine, (2026): -, doi: 10.22038/rcm.2026.93558.1576
VANCOUVER
Nosratzehi, S., Nosratzehi, M., Dehvari, A., Mohammadi, M. Epidemiology of Gout in Southeast Iran: Unexpected Risk Factor Patterns in a Population-Based Study. Reviews in Clinical Medicine, 2026; (): -. doi: 10.22038/rcm.2026.93558.1576